amobarbital has been researched along with Catatonic Schizophrenia in 9 studies
Amobarbital: A barbiturate with hypnotic and sedative properties (but not antianxiety). Adverse effects are mainly a consequence of dose-related CNS depression and the risk of dependence with continued use is high. (From Martindale, The Extra Pharmacopoeia, 30th ed, p565)
amobarbital : A member of the class of barbiturates that is pyrimidine-2,4,6(1H,3H,5H)-trione substituted by a 3-methylbutyl and an ethyl group at position 5. Amobarbital has been shown to exhibit sedative and hypnotic properties.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The amobarbital interview is a safe and simple technique to discriminate functional from organic illness, thus avoiding unnecessary medical and surgical treatment, neglected illness, and inappropriate disposition." | 1.26 | The amobarbital interview. ( Fauman, BJ; Wettstein, RM, 1979) |
| "A brief differential diagnosis of catatonia is also included." | 1.26 | Catatonia and systemic lupus erythematosus. ( Kronfol, Z; Schlesser, M; Tsuang, MT, 1977) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 8 (88.89) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (11.11) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fink, M | 1 |
| Taylor, MA | 1 |
| Linn, L | 1 |
| Pellegrini, AJ | 1 |
| Putman, P | 1 |
| Tollefson, GD | 1 |
| Pulman, J | 1 |
| Lal, S | 1 |
| Wettstein, RM | 1 |
| Fauman, BJ | 1 |
| Dysken, MW | 1 |
| Steinberg, J | 1 |
| Davis, JM | 1 |
| Kronfol, Z | 1 |
| Schlesser, M | 1 |
| Tsuang, MT | 1 |
| Frost, LH | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| "Interventional Triple-negative Placebo-controlled Personalized Prospective Study Evaluation of the Efficacy and Safety of Noninvasive Neuromodulation of TMS in Subjects With Catatonia"[NCT06176456] | 60 participants (Anticipated) | Interventional | 2023-11-01 | Recruiting | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
9 other studies available for amobarbital and Catatonic Schizophrenia
| Article | Year |
|---|---|
Catatonia: subtype or syndrome in DSM?
Topics: Amobarbital; Catatonia; Diagnostic and Statistical Manual of Mental Disorders; Humans; Lorazepam; Me | 2006 |
Intravenous sedatives and catatonia.
Topics: Amobarbital; Arousal; Catatonia; Humans; Hypnotics and Sedatives; Schizophrenia, Catatonic | 1984 |
The Amytal interview in the diagnosis of late onset psychosis with cultural features presenting as catatonic stupor.
Topics: Amobarbital; Black or African American; Catatonia; Diagnosis, Differential; Humans; Male; Medicine, | 1984 |
The amobarbital interview in the differential diagnosis of catatonia.
Topics: Amobarbital; Catatonia; Diagnosis, Differential; Female; Humans; Middle Aged; Neurocognitive Disorde | 1982 |
Physical assault during the amytal interview.
Topics: Adult; Amobarbital; Humans; Interview, Psychological; Male; Schizophrenia, Catatonic; Violence | 1982 |
The amobarbital interview.
Topics: Adult; Amnesia; Amobarbital; Emergency Service, Hospital; Female; Humans; Hysteria; Interview, Psych | 1979 |
Sodium amobarbital response during simulated catatonia.
Topics: Adult; Amobarbital; Humans; Schizophrenia, Catatonic; Volition | 1979 |
Catatonia and systemic lupus erythematosus.
Topics: Adult; Amobarbital; Catatonia; Diagnosis, Differential; Female; Humans; Lupus Erythematosus, Systemi | 1977 |
Methylphenidate in amytal-resistant mutism.
Topics: Adult; Amobarbital; Humans; Infusions, Intravenous; Male; Methylphenidate; Mutism; Schizophrenia, Ca | 1989 |